A case of intratracheal inflammatory pseudotumour mimicking asthma bronchiale

E. Öztürk, V. Çaglayan, A. Kosar, G. Dabak, E. Okur, A. Saygi (Istanbul, Turkey)

Source: Annual Congress 2003 - Asthma: potpourri
Session: Asthma: potpourri
Session type: Thematic Poster Session
Number: 2690

Congress or journal article abstract

Rating: 0
You must login to grade this presentation.

Share or cite this content

Citations should be made in the following way:
E. Öztürk, V. Çaglayan, A. Kosar, G. Dabak, E. Okur, A. Saygi (Istanbul, Turkey). A case of intratracheal inflammatory pseudotumour mimicking asthma bronchiale. Eur Respir J 2003; 22: Suppl. 45, 2690

You must login to share this Presentation/Article on Twitter, Facebook, LinkedIn or by email.

Member's Comments

No comment yet.
You must Login to comment this presentation.


Related content which might interest you:
Eosinophilic inflammation and asthma control
Source: Annual Congress 2009 - Inflammation and airways
Year: 2009

How to treat bronchial granuloma in chronic granulomatous disease?
Source: Eur Respir J 2004; 24: Suppl. 48, 49s
Year: 2004

Bronchiectasis associated with inflammatory bowel disease
Source: Eur Respir Mon 2011; 52: 163-177
Year: 2011


Eosinophilic airway inflammation in COPD and asthma
Source: Annual Congress 2008 - Invasive and noninvasive measurements of lung inflammation
Year: 2008


Clinical outcome of eosinophilic airway inflammation in chronic airway diseases including nonasthmatic eosinophilic bronchitis
Source: International Congress 2017 – Asthma and allergy: from the bench to the bedside
Year: 2017

Eosinophilic refractory inflammation in OCS-dependent severe asthma
Source: Virtual Congress 2021 – Severe asthma: evaluation using patient-reported outcome measures (PROMs) and biomarkers, comorbidities and treatments
Year: 2021


Effects of omalizumab on markers of eosinophilic inflammation in patients with severe allergic asthma
Source: Annual Congress 2011 - Biomarkers and exacerbations of asthma and COPD
Year: 2011


Bronchial hyperreactivity in patients with inflammatory bowel disease
Source: Eur Respir J 2003; 22: Suppl. 45, 480s
Year: 2003

Inflammatory mediators in eosinophilic COPD phenotype and asthma with fixed airflow obstruction
Source: International Congress 2018 – Understanding the immunopathology that underlies airway obstructive diseases
Year: 2018




Hypereosinophilic obliterative bronchiolitis: a distinct, unrecognised syndrome
Source: Eur Respir J 2013; 41: 1126-1134
Year: 2013



Pathogenesis of allergic granulomatous angitis in an experimental model with mice
Source: Eur Respir J 2006; 28: Suppl. 50, 227s
Year: 2006

The pathological feature of airway inflammation in eosinophilic bronchitis
Source: Eur Respir J 2005; 26: Suppl. 49, 282s
Year: 2005

Benralizumab for severe asthma associated with extra-airway eosinophilic diseases
Source: Virtual Congress 2020 – Monoclonal antibodies in asthma
Year: 2020


Characterisation of severe obliterative bronchiolitis in rheumatoid arthritis
Source: Eur Respir J 2009; 33: 1053-1061
Year: 2009



Chronic paranasal sinusitis exacerbates allergic inflammation in patients with asthma and contributes to refractoriness to treatment
Source: Annual Congress 2012 - Clinical aspects and treatment of asthma and allergic respiratory diseases
Year: 2012

Incidence of allergic asthma in patients with sarcoidosis
Source: Eur Respir J 2006; 28: Suppl. 50, 232s
Year: 2006

Diffuse idiopathic pulmonary neuroendocrine hyperplasia, chronic eosinophilic pneumonia, and asthma
Source: Eur Respir J 2009; 34: 1489-1492
Year: 2009


The study of C5a complement component in patients with idiopathic pulmonary fibrosis, toxic fibrosing alveolitis and extrinsic allergic alveolitis
Source: Eur Respir J 2001; 18: Suppl. 33, 108s
Year: 2001

Allergic inflammation markers for earlier diagnosis of bronchial asthma in patients with allergic rhinitis
Source: Annual Congress 2008 - Asthma: growing understanding of influential factors
Year: 2008